TABLE 1.
Origin | DAMP | Receptor | Function (standard font = pro-inflammatory; italics = anti-inflammatory) | References |
Extracellular Matrix | Aggrecan 32 mer fragment | TLR2 | (iNOS), CCL2, IL-1α, IL-6, MMP12 MMP13 and ADAMTS5 | Stevens et al., 2008 |
Biglycan | TLR2/4 | Increases levels of reactive oxygen species, CXCL-1, CCL2 and HSP70, and activates NLRP3 inflammasome by Caspase-1 and the maturation of IL-1β Activating a TLR co-adaptor that activates IFN1 signaling | Frey et al., 2013; Schaefer, 2014; Roedig et al., 2019 | |
Decorin | TLR2/4 | Decreases TGFβ1 and IL-10 and increases levels of apoptosis | Merline et al., 2011 | |
*Fibronectin | TLR2/4 | Promotes pro-inflammatory mediators and phagocytosis by macrophages | Haruta et al., 2013; Fei et al., 2018 | |
Fibrinogen | TLR4 | Activation of monocytes | Al-Ofi et al., 2014 | |
LMW-HA | TLR2/4 | Activates NLRP3 inflammasome by Caspase-1 and the maturation of IL-1β. Activates NF-kB | Merline et al., 2011 | |
HMW-HA | TLR2 | Activates a TLR co-adaptor that activates IFN1 signaling | Scheibner et al., 2006; Frey et al., 2013 | |
Heparin sulfate | TLR4, RAGE | Activation of NF-kB | Xu et al., 2011 | |
Tenascin C | TLR4 | Synthesis of pro-inflammatory cytokines | Midwood et al., 2009 | |
Versican | TLR2/4 CD14 | IL-6, IL-1β, Il-12 and CCL2 production Increasing IL-6 (anti-inflammatory pathways), IL-10 | Wight et al., 2014 | |
Cytosolic | ATP | P2XR P2YR | Attracts macrophages by inflammasome activation MAPK wound healing response | Venereau et al., 2015 |
Cyclophilin | CD 147 | Chemotaxis and the production of pro-inflammatory factors | Burkrinsky, 2014 | |
F-actin | DNGR1 | DNGR1 recognizes the released F-actin, which causes the uptake of damaged or dead cells | Brown, 2012 | |
Heat Shock Protein | TLR2/4 | MyD88 dependent activation of NF-kB | Tolle and Standiford, 2013; Relja et al., 2018 | |
S100 proteins | TLR4, CD147 RAGE | Leads to apoptosis and activates ERK and NF-kB or AP1 | Ghavami et al., 2010; Xia et al., 2018 | |
*Soluble amyloid beta | TLR2/4 | Enhanced TNF driven inflammation | Wang et al., 2019 | |
Uric Acid | NLRP3 | Inflammasome activation and induction of IL-1β maturation | Braga et al., 2017 | |
Mitochondrial | mtDNA | TLR9 | p38 MAPK and NF-kB activation | Zhang et al., 2010; Zhang et al., 2014; Magna and Pisetsky, 2016; Bao et al., 2016 |
Nuclear | *Cell free DNA | TLR9 | Activation of NF-kB and AP1 | Magna and Pisetsky, 2016 |
Circulating Histones | TLR9 | Inflammation through the activation of NF-kB | Huang et al., 2011; Kawai et al., 2016 | |
Extracellular self RNA | TLR7 TLR3 | Sensitizes other TLR working synergistically with their other ligands MAPK, NF-κB, and IRF-5/7 pathways through MyD88 signaling | Karikó et al., 2004; Cavassani et al., 2008; Thompson et al., 2011; Noll et al., 2017; Petes et al., 2017 | |
*HMGB1 | TLR2 TLR4 TLR9 | Activation of NF-kB, and MAPK signaling though ERK and p38, release of MMPs | Qin et al., 2006; Nie et al., 2016 | |
Menon et al., 2011; Bredeson et al., 2014; Plazyo et al., 2016 | ||||
IL-1α | IL-1R | MAPK signaling and NF-kB activation | Betheloot and Latz, 2017 | |
IL-33 | ST2 | NF-kB activation and TNF production | Isnadi et al., 2018 | |
SAP130 | Mincle | Triggering pro-inflammatory cytokine secretion | Zhou et al., 2016; Patkin et al., 2017 |
* denotes has been studied in the fetal membranes or cells of the fetal membranes. ADAMTS5, ADAM metallopeptidase with Thrombospondin type 1 motif 5; AP-1, Activator protein 1; CD, Cluster Differentiation; DNGR1, Dendritic cell natural killer lectin group receptor-1; ERK, extracellular-signal-regulated kinase; HSP, Heat Shock protein; IFN1, Interferon; IL, Interleukin; iNOS, Inducible Nitric Oxide; IRF, Interferon regulatory factors; MMP, Matrix Metalloproteinase; MyD88, myeloid differentiation primary response protein 88; NF-kB, Nuclear Factor Kappa B; NLRP3, LRR- and pyrin domain-containing protein 3; RAGE, advanced glycation end products; ST2, suppression of tumorigenicity 2; TGF, Transforming growth factor; TLR, Toll-like receptor; TNF, Tumor Necrosis Factor.